Czech National Bank Increases Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Czech National Bank grew its position in Henry Schein, Inc. (NASDAQ:HSIC) by 4.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 27,034 shares of the company’s stock after acquiring an additional 1,223 shares during the period. Czech National Bank’s holdings in Henry Schein were worth $1,871,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. FMR LLC boosted its holdings in Henry Schein by 7.8% in the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock valued at $239,177,000 after purchasing an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP lifted its holdings in shares of Henry Schein by 30.0% in the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock valued at $189,540,000 after buying an additional 600,000 shares during the period. Nuance Investments LLC boosted its stake in shares of Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after buying an additional 414,748 shares in the last quarter. Burgundy Asset Management Ltd. boosted its stake in shares of Henry Schein by 1.0% in the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock valued at $105,148,000 after buying an additional 16,476 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Henry Schein by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,634,384 shares of the company’s stock worth $104,764,000 after acquiring an additional 149,517 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.14% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have commented on HSIC shares. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Evercore ISI raised their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. Seven investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Henry Schein currently has an average rating of “Moderate Buy” and an average target price of $79.40.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $71.75 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The business’s fifty day moving average price is $72.22 and its two-hundred day moving average price is $70.58. The stock has a market cap of $8.95 billion, a PE ratio of 29.53, a price-to-earnings-growth ratio of 1.90 and a beta of 0.89. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter last year, the company earned $1.32 earnings per share. On average, analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.